HemaClear is used for bloodless orthopedic limb surgery. It is a sterile and cost-effective device that exsanguinates, occludes and provides a clearer surgical field in a single disposable product. The launch also marks HemaClear’s introduction to the German market.
Related Articles on Orthopedic Devices:
Smith & Nephew Voluntarily Withdraws Hip System Component
Maine Plans Statewide Medical Image Archive Pilot
Amedica Names Brian McEntire Chief Technology Officer
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.